Harriet de Wit
Director/Miembro de la Junta en PHARMALA BIOTECH HOLDINGS INC. .
Fortuna: 15 800 $ al 30/04/2024
Cargos activos de Harriet de Wit
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director/Miembro de la Junta | 21/03/2021 | - |
| The University of Chicago | Corporate Officer/Principal | - | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Historial de carrera de Harriet de Wit
Formación de Harriet de Wit.
| University of Calgary | Undergraduate Degree |
| Concordia University | Doctorate Degree |
Estadísticas
Internacional
| Canadá | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Harriet de Wit
- Experiencia
